Interactions between HIV-1 Vif and human ElonginB-ElonginC are important for CBF-β binding to Vif. - Test2 - elhamkhani - TriplyDB

Interactions between HIV-1 Vif and human ElonginB-ElonginC are important for CBF-β binding to Vif.

Interactions between HIV-1 Vif and human ElonginB-ElonginC are important for CBF-β binding to Vif.

http://www.wikidata.org/entity/Q37153444

about

Suppression of APOBEC3-mediated restriction of HIV-1 by Vif The Road Less Traveled: HIV's Use of Alternative Routes through Cellular Pathways Insight into the HIV-1 Vif SOCS-box-ElonginBC interaction Structural analysis of viral infectivity factor of HIV type 1 and its interaction with A3G, EloC and EloB Identification of HIV-1 Vif regions required for CBF-β interaction and APOBEC3 suppression Role of cullin-elonginB-elonginC E3 complex in bovine immunodeficiency virus and maedi-visna virus Vif-mediated degradation of host A3Z2-Z3 proteins Requirement of HIV-1 Vif C-terminus for Vif-CBF-β interaction and assembly of CUL5-containing E3 ligase Identification of a novel HIV-1 inhibitor targeting Vif-dependent degradation of human APOBEC3G protein.Redoxal, an inhibitor of de novo pyrimidine biosynthesis, augments APOBEC3G antiviral activity against human immunodeficiency virus type 1.The HDAC6/APOBEC3G complex regulates HIV-1 infectiveness by inducing Vif autophagic degradation.HIV-1 Vif N-terminal motif is required for recruitment of Cul5 to suppress APOBEC3.The ubiquitin-conjugating system: multiple roles in viral replication and infection.Clues for two-step virion infectivity factor regulation by core binding factor beta.Determinants of efficient degradation of APOBEC3 restriction factors by HIV-1 Vif.Moloney leukemia virus 10 (MOV10) inhibits the degradation of APOBEC3G through interference with the Vif-mediated ubiquitin-proteasome pathway.

P2860

Q27025150-0C4F3863-712A-4CD3-ABB5-9F321AE17FD9 Q27027607-EF621464-2840-473A-9DF3-FF496583BA51 Q27680599-3C10AF48-760E-4983-83F6-C8BE4144A7C8 Q28540150-D635ED79-815C-4921-AA3E-3D385DA7CFA8 Q33583855-75680864-50A0-444C-9DB0-AC18D5F8B1F9 Q34233314-A90CB533-29C7-4D9D-9054-55E2E413679A Q34695564-5DCB991C-A423-4219-9F5B-A665148A3655 Q35451347-D75C05B4-3261-4B68-AE4D-3706394D8E69 Q35682519-3F72C2C9-9922-4D6B-8761-8C9102F36BCC Q35776289-CD18BCB2-4F58-41AB-AF46-09B3E2492AC5 Q37608208-98C5D015-5F4A-4A32-8B22-BE9205A987EB Q38210024-1C2483E8-3B89-4661-9402-24FE386CA663 Q38703114-AB018038-52E8-48C3-88BB-5FC9BB557CCD Q38951329-30012E55-03F8-4274-B8A0-A0272923A9E2 Q47135036-C8E8E2F7-9F50-4CD1-9BB9-A153F8FCFCCD

P2860

Interactions between HIV-1 Vif and human ElonginB-ElonginC are important for CBF-β binding to Vif.

http://www.wikidata.org/entity/Q37153444

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 29 August 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Interactions between HIV-1 Vif ...... tant for CBF-β binding to Vif.

@en

Interactions between HIV-1 Vif ...... tant for CBF-β binding to Vif.

@nl

type

label

Interactions between HIV-1 Vif ...... tant for CBF-β binding to Vif.

@en

Interactions between HIV-1 Vif ...... tant for CBF-β binding to Vif.

@nl

prefLabel

Interactions between HIV-1 Vif ...... tant for CBF-β binding to Vif.

@en

Interactions between HIV-1 Vif ...... tant for CBF-β binding to Vif.

@nl

P1433

Q37153444-95C120B8-E080-4C13-80FD-0A54BE146CCC

P1476

Q37153444-7112F454-B008-43B9-9B33-6239A5C9E026

P2093

Q37153444-01B08FC5-FE64-4E8C-9D82-552CDBBDB65A

Q37153444-10FEB23A-B594-4248-B1A5-7249AD18C09C

Q37153444-266A4387-7EBA-4306-A2B7-D95051CAD98D

Q37153444-31669DC9-FF48-46B8-BBBE-E83AECEBD197

Q37153444-31AD0246-0186-4030-893B-EAC2F8CD3972

Q37153444-35B68EE3-502C-47BD-8E55-56999E92328D

Q37153444-4478598B-40CA-46EC-A65C-D3B7DE732D96

Q37153444-46BC5B65-C872-4772-BBF2-554DB00560B8

Q37153444-54214716-5364-4414-9BF8-0ECFEE065A48

Q37153444-59D51695-B53C-456B-A84D-0DDFCDF756E7

P2860

Q37153444-00246D0F-4698-4F86-9E15-773B55149E8C

Q37153444-0497A759-C57B-4F4D-8EB1-7DDC81C436AF

Q37153444-04A3EFA4-10E3-45AB-91E6-82D303074CD1

Q37153444-051C6022-EBF2-488B-9144-A689905AF4B2

Q37153444-0C0C7E8F-6C59-43F6-AA5B-2039E3C15CE0

Q37153444-12BA455A-593C-4868-9DE2-04F4AE2AA54E

Q37153444-159D0066-1003-449A-885B-6D5255B6079D

Q37153444-191F99BF-A5BA-41A7-AD51-FEE49745AB1D

Q37153444-19893552-4CB1-4CF9-BC69-7981CAAA8E1D

Q37153444-1D20A87D-8D30-4D2B-8E64-0284A6E50008

P2888

Q37153444-2D808E82-BC9F-423A-A941-988C20B1D689

P304

Q37153444-7CC8A38F-BF38-45FC-9FA8-18FEEFFA8A02

P31

Q37153444-3A9E50FF-A5F7-4DF5-B703-4F4D1827BF2F

P356

Q37153444-78C66F22-0A1A-4ABF-8ECF-E6D25B59A3DF

P478

Q37153444-112809EF-389F-4AE8-85BE-65EBFB007AC2

P577

Q37153444-8C1E0108-1485-4674-B8A3-10122F30AB09

P5875

Q37153444-354F73C1-A252-46FE-9DD0-7FC214D1B94E

P6179

Q37153444-7692964D-6F45-4E2B-8E52-6D697347D8E0

P698

Q37153444-EBA57A17-BC48-496D-9E33-D350E6F77642

P921

Q37153444-E380702B-F58E-4F7B-9226-682B4614D0C4

P932

Q37153444-446AD494-364D-4C2E-967B-AB1BB29465DB

P356

1742-4690-10-94

P1433

P1476

Interactions between HIV-1 Vif ...... tant for CBF-β binding to Vif.

@en

P2093

Bin Yu

http://www.w3.org/2001/XMLSchema#string

Chu Wang

http://www.w3.org/2001/XMLSchema#string

Donglai Liu

http://www.w3.org/2001/XMLSchema#string

Haihong Zhang

http://www.w3.org/2001/XMLSchema#string

Hui Wu

http://www.w3.org/2001/XMLSchema#string

Jiawen Wang

http://www.w3.org/2001/XMLSchema#string

Jiaxin Wu

http://www.w3.org/2001/XMLSchema#string

Jingyao Zhang

http://www.w3.org/2001/XMLSchema#string

Mingyu Lv

http://www.w3.org/2001/XMLSchema#string

Tao Zuo

http://www.w3.org/2001/XMLSchema#string

P2860

Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function

Global landscape of HIV-human protein complexes

T-cell differentiation factor CBF-β regulates HIV-1 Vif-mediated evasion of host restriction

Elongin (SIII): a multisubunit regulator of elongation by RNA polymerase II

Differential requirement for conserved tryptophans in human immunodeficiency virus type 1 Vif for the selective suppression of APOBEC3G and APOBEC3F.

Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication

Synthetic peptides define critical contacts between elongin C, elongin B, and the von Hippel-Lindau protein

A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins

Positive regulation of general transcription factor SIII by a tailed ubiquitin homolog

The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation

P2888

1742-4690-10-94

P304

94

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1742-4690-10-94

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2013-08-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256289139

http://www.w3.org/2001/XMLSchema#string

P6179

1024743573

http://www.w3.org/2001/XMLSchema#string

P698

23988114

http://www.w3.org/2001/XMLSchema#string

P921

P932

3765967

http://www.w3.org/2001/XMLSchema#string